CAU Scholar's Space: Kim, Su Hyun

Detailed Information

Kim, Su Hyun (김수현)

의과대학 (의학부(임상-광명))

Research Area

Tel 031-670-1440
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Mortality:6||mortality:6||Hemodialysis:6||Kidney transplantation:5||Acute kidney injury:5||Dialysis:4||Chronic kidney disease:4||Renal dialysis:4||Peritoneal dialysis:3||Treatment:3||Chronic kidney failure:3||Incidence:3||Fabry disease:3||Cyclosporine:3||chronic kidney disease:3||Survival:2||Hemodialysis units:2||acute kidney injury:2||Chronic renal insufficiency:2||Guidelines:2||acute renal failure:2||Practice guideline:2||Microcirculation:2||Phase angle:2||Hypertension:2||Evidencebased practice:2||Nephrotoxicity:2||indoxyl sulfate:2||chronic hemodialysis:2||cardiovascular:2||AST120:2||Biopsy:2||Sarcopenia:2||Leflunomide:2||신장이식:2||GRADE approach:2||Gait speed:2||Endstage renal disease:2||Quality of life:2||Gout:2||peritoneal dialysis:2||Cytomegalovirus:1||Daily Fluid Balance:1||Depression:1||Diabetes mellitus:1||Diabetic nephropathies:1||Dialysis adequacy:1||Diet record:1||Education:1||Endocarditis:1||Endothelial cell:1||Enzyme replacement therapy:1||Epoetinalpha:1||FetuinA:1||Fineneedle:1||GLA:1||Glomerulonephritis:1||Graft Rejection:1||Graft rejection:1||Guideline:1||Haemodialysis:1||Handgrip strength:1||Healthrelated quality of life:1||Heat shock protein 70:1||Hemoconcentration:1||Hemodiafiltration:1||Hospital:1||Hypoalbuminemia:1||Hypokalemia:1||Hypotension:1||Idiopathic:1||Immunoglobulin:1||Inflammatory markers:1||Interferonα:1||Interleukin10:1||Interleukin1alpha:1||Intracellular signaling peptides and proteins:1||Kidney:1||Kidney Failure:1||Kidney Health Plan 2033:1||Kidney Transplantation:1||Kidney diseases:1||Korean Society of Nephrology:1||Lipomatosis:1||Lipopolysaccharide:1||Liposuction:1||Lung cancer:1||Lymphoma:1||MAPKinase:1||Macrophage:1||Malignancy:1||Malnutrition:1||Mycobacterium avium complex:1||N3oxododecanoyl homoserine lactone:1||Nonprescription drugs:1||Nutrition:1||Organ Failure:1||Osteoprotegerin:1||Outcomes:1||PDA10:1||Panax ginseng:1||Pancreas:1||PauciImmune Vasculitis:1||Perfusion:1||Prevalence:1||Problemfocused Coping strategy:1||Quantitative Evaluation:1||Quantitative electroencephalogram:1||Quorumsensing molecule:1||Reactive oxygen species:1||Receptorinteracting protein kinase 1:1||Regulatory:1||Renal infarction:1||Renal insufficiency:1||Renal recovery:1||Renal replacement therapy:1||Renal transplantation:1||Rhabdomyolysis:1||Risk factor:1||Rituximab:1||Sepsis:1||Subjective global assessment:1||Survey:1||Surveys and questionnaire:1||Systemic capillary leak syndrome:1||Tlymphocytes:1||Therapeutic equivalence:1||Therapeutics:1||Transcranial magnetic stimulation:1||Tuberculosis:1||Uremia:1||Uremia middle molecule toxins:1||Uremic pruritus:1||Vascular Calcification:1||Vascular stiffness:1||acid:1||acute hepatitis A:1||acute kidney injury (AKI):1||acute pyelonephritis:1||alphagalactosidase A:1||apoptosis:1||beta(2)Microglobulin:1||bioelectrical impedance analysis:1||bioimpedance:1||blood pressure:1||cardiogenic etiology:1||cardiovascular event:1||case series:1||cefepime:1||cefepimeinduced encephalopathy:1||chronic:1||chronic cyclosporine nephropathy:1||chronic renal failure:1||cisplatin:1||complement:1||continuous renal replacement therapy:1||critical illness:1||cystatin C:1||desmopressin:1||diabetes mellitus:1||dialysis:1||diuretics:1||downtime:1||electric impedance:1||electrolyte:1||endstage renal disease:1||endstage renal disease (ESRD):1||enzyme replacement therapy:1||epithelialtomesenchymal transition:1||euvolemia:1||fluid balance:1||fluid overload:1||globotriaosylceramide:1||glomerular filtration rate:1||hospital:1||hospitalisation:1||hyperalgesia:1||hyponatremia:1||indoxyl sulphate:1||inflammation:1||innate immunity:1||kidney function:1||killer cells:1||left ventricular function:1||metabolic syndrome:1||muscle:1||myostatin:1||natural:1||nephrolithiasis:1||nephrotoxicity:1||nutritional loss:1||obstructive uropathy:1||osteoporosis:1||outcome:1||outcomes:1||oxidative stress:1||parenchymal perfusion defect:1||reduced glomerular filtration rate:1||renal blood flow:1||renal dialysis:1||renal outcome:1||renal replacement therapy.:1||residual kidney function:1||sarcopenia:1||sepsis:1||sirolimus:1||survival:1||thiazides:1||tissue perfusion:1||transplantation:1||urolithiasis:1||volume:1||weight loss:1||감염성 심내막염:1||거대세포바이러스:1||급성 신손상:1||말기신부전:1||면역글로불린:1||발병률:1||생존율:1||신이식:1||아스페르길루스:1||악성종양:1||요독증:1||지방흡인술:1||투석:1||횡문근융해증:1||Acute kidney injury (AKI):1||Adherence:1||Alkalosis:1||Anaemia:1||Angiotensin receptor blockers:1||Angiotensinconverting enzyme inhibitors:1||AntiNeutrophil Cytoplasmic Antibody:1||Aspergillus:1||Asymptomatic hyperuricemia:1||BK virus:1||BK 바이러스:1||Behindthecounter drugs:1||Beta 2microglobulin:1||Bicarbonates:1||Bioelectrical impedance:1||Bioelectrical impedance analysis:1||Bioimpednace:1||Blood Pressure:1||Blood flow rate:1||Body mass index:1||Bone marrow:1||COVID19 mRNA Vaccines:1||Caffeine:1||Calcification:1||Case report:1||Chemotherapy:1||Chronic:1||Chronic Kidney Disease:1||Chronic hepatitis C:1||Chronic kidney diseases:1||Cisplatin:1||Clodronate:1||Coffee:1||Colistin:1||Comorbidity:1||Continuous Renal Replacement Therapy:1||Contrastenhanced Ultrasound:1||Coping strategy:1||Coronavirus Disease 2019:1||Critically Ill Patients:1||

STATISTICS: Total View :6,850,190; Today View :4,496

RSS_1.0 RSS_2.0 ATOM_1.0

84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE